

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | low-density lipoprotein particle clearance (GO:0034383) | 6.64222223 |
| 2 | triglyceride catabolic process (GO:0019433) | 6.08918356 |
| 3 | regulation of sequestering of triglyceride (GO:0010889) | 6.03975400 |
| 4 | positive T cell selection (GO:0043368) | 5.91912832 |
| 5 | neutral lipid catabolic process (GO:0046461) | 5.82729061 |
| 6 | acylglycerol catabolic process (GO:0046464) | 5.82729061 |
| 7 | negative T cell selection (GO:0043383) | 5.80068933 |
| 8 | negative regulation of cell killing (GO:0031342) | 5.79743801 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.79743801 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.68637370 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 5.50139145 |
| 12 | valine metabolic process (GO:0006573) | 5.32715545 |
| 13 | negative thymic T cell selection (GO:0045060) | 5.31363547 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.23861301 |
| 15 | biotin metabolic process (GO:0006768) | 5.18698631 |
| 16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.04995972 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.04316915 |
| 18 | brown fat cell differentiation (GO:0050873) | 4.98636076 |
| 19 | activated T cell proliferation (GO:0050798) | 4.97633079 |
| 20 | cellular response to interleukin-15 (GO:0071350) | 4.96493338 |
| 21 | fatty acid transmembrane transport (GO:1902001) | 4.83850705 |
| 22 | response to interleukin-15 (GO:0070672) | 4.82701624 |
| 23 | white fat cell differentiation (GO:0050872) | 4.69178024 |
| 24 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.67935051 |
| 25 | plasma lipoprotein particle clearance (GO:0034381) | 4.67467952 |
| 26 | positive thymic T cell selection (GO:0045059) | 4.61541382 |
| 27 | glycerolipid catabolic process (GO:0046503) | 4.38841951 |
| 28 | T cell selection (GO:0045058) | 4.36670331 |
| 29 | triglyceride biosynthetic process (GO:0019432) | 4.31911276 |
| 30 | regulation of triglyceride catabolic process (GO:0010896) | 4.29829477 |
| 31 | regulation of cholesterol storage (GO:0010885) | 4.29413605 |
| 32 | response to dietary excess (GO:0002021) | 4.26609228 |
| 33 | * fatty acid beta-oxidation (GO:0006635) | 4.25010341 |
| 34 | neutral lipid biosynthetic process (GO:0046460) | 4.21279364 |
| 35 | acylglycerol biosynthetic process (GO:0046463) | 4.21279364 |
| 36 | T cell migration (GO:0072678) | 4.20462102 |
| 37 | complement activation, alternative pathway (GO:0006957) | 4.19688508 |
| 38 | carnitine shuttle (GO:0006853) | 4.17127521 |
| 39 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.15521540 |
| 40 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.11906728 |
| 41 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.10529803 |
| 42 | thymic T cell selection (GO:0045061) | 4.04999156 |
| 43 | triglyceride homeostasis (GO:0070328) | 4.03847114 |
| 44 | acylglycerol homeostasis (GO:0055090) | 4.03847114 |
| 45 | fatty acid homeostasis (GO:0055089) | 4.03652393 |
| 46 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.02358771 |
| 47 | L-phenylalanine catabolic process (GO:0006559) | 4.02358771 |
| 48 | * fatty acid oxidation (GO:0019395) | 3.99183940 |
| 49 | * lipid oxidation (GO:0034440) | 3.98427011 |
| 50 | triglyceride metabolic process (GO:0006641) | 3.98310732 |
| 51 | * positive regulation of fatty acid oxidation (GO:0046321) | 3.95537823 |
| 52 | interferon-gamma production (GO:0032609) | 3.94520609 |
| 53 | * positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.92276108 |
| 54 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.92201955 |
| 55 | regulation of gamma-delta T cell activation (GO:0046643) | 3.89390461 |
| 56 | lipid storage (GO:0019915) | 3.88632314 |
| 57 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.87383002 |
| 58 | sulfur amino acid catabolic process (GO:0000098) | 3.87293059 |
| 59 | acetyl-CoA metabolic process (GO:0006084) | 3.86354148 |
| 60 | branched-chain amino acid catabolic process (GO:0009083) | 3.85735539 |
| 61 | negative regulation of T cell mediated immunity (GO:0002710) | 3.84067582 |
| 62 | branched-chain amino acid metabolic process (GO:0009081) | 3.82989097 |
| 63 | * fatty acid catabolic process (GO:0009062) | 3.82782983 |
| 64 | thioester biosynthetic process (GO:0035384) | 3.79370406 |
| 65 | acyl-CoA biosynthetic process (GO:0071616) | 3.79370406 |
| 66 | acylglycerol metabolic process (GO:0006639) | 3.79129173 |
| 67 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.75482521 |
| 68 | neutral lipid metabolic process (GO:0006638) | 3.74623190 |
| 69 | phospholipid homeostasis (GO:0055091) | 3.74537240 |
| 70 | L-phenylalanine metabolic process (GO:0006558) | 3.74315576 |
| 71 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.74315576 |
| 72 | * positive regulation of lipid catabolic process (GO:0050996) | 3.71549363 |
| 73 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.67889707 |
| 74 | alanine transport (GO:0032328) | 3.65502762 |
| 75 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.62325527 |
| 76 | negative regulation of lipase activity (GO:0060192) | 3.59838844 |
| 77 | positive regulation of tolerance induction (GO:0002645) | 3.58301897 |
| 78 | regulation of regulatory T cell differentiation (GO:0045589) | 3.57627854 |
| 79 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.53420560 |
| 80 | short-chain fatty acid metabolic process (GO:0046459) | 3.51164300 |
| 81 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.48626091 |
| 82 | regulation of T cell tolerance induction (GO:0002664) | 3.47726210 |
| 83 | * monocarboxylic acid catabolic process (GO:0072329) | 3.44828362 |
| 84 | protein-lipid complex remodeling (GO:0034368) | 3.44050480 |
| 85 | macromolecular complex remodeling (GO:0034367) | 3.44050480 |
| 86 | plasma lipoprotein particle remodeling (GO:0034369) | 3.44050480 |
| 87 | 2-oxoglutarate metabolic process (GO:0006103) | 3.43896696 |
| 88 | regulation of triglyceride metabolic process (GO:0090207) | 3.40986762 |
| 89 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.39737931 |
| 90 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.37198303 |
| 91 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.36848440 |
| 92 | carnitine transmembrane transport (GO:1902603) | 3.36756890 |
| 93 | lipid particle organization (GO:0034389) | 3.34615516 |
| 94 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.34319139 |
| 95 | urea cycle (GO:0000050) | 3.31919093 |
| 96 | urea metabolic process (GO:0019627) | 3.31919093 |
| 97 | reverse cholesterol transport (GO:0043691) | 3.31817591 |
| 98 | oxaloacetate metabolic process (GO:0006107) | 3.31342069 |
| 99 | * positive regulation of fatty acid metabolic process (GO:0045923) | 3.30728269 |
| 100 | B cell receptor signaling pathway (GO:0050853) | 3.30035641 |
| 101 | amino-acid betaine metabolic process (GO:0006577) | 3.27101234 |
| 102 | linoleic acid metabolic process (GO:0043651) | 3.25990777 |
| 103 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.25087070 |
| 104 | positive regulation of cholesterol transport (GO:0032376) | 3.23266230 |
| 105 | positive regulation of sterol transport (GO:0032373) | 3.23266230 |
| 106 | coenzyme A biosynthetic process (GO:0015937) | 3.23054787 |
| 107 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.21455140 |
| 108 | regulation of tolerance induction (GO:0002643) | 3.20056364 |
| 109 | * regulation of fatty acid beta-oxidation (GO:0031998) | 3.18591042 |
| 110 | T cell receptor signaling pathway (GO:0050852) | 3.17967767 |
| 111 | high-density lipoprotein particle remodeling (GO:0034375) | 3.16948095 |
| 112 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.15846771 |
| 113 | regulation of B cell differentiation (GO:0045577) | 3.15082124 |
| 114 | positive regulation of B cell differentiation (GO:0045579) | 3.15072359 |
| 115 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.13117908 |
| 116 | carnitine metabolic process (GO:0009437) | 3.12637613 |
| 117 | amino-acid betaine transport (GO:0015838) | 3.11972106 |
| 118 | carnitine transport (GO:0015879) | 3.11972106 |
| 119 | * regulation of fatty acid oxidation (GO:0046320) | 3.11758834 |
| 120 | tolerance induction (GO:0002507) | 3.11539752 |
| 121 | regulation of cholesterol transport (GO:0032374) | 3.11111576 |
| 122 | regulation of sterol transport (GO:0032371) | 3.11111576 |
| 123 | aromatic amino acid family catabolic process (GO:0009074) | 3.10713918 |
| 124 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.09160380 |
| 125 | low-density lipoprotein particle remodeling (GO:0034374) | 3.07646129 |
| 126 | nitrogen cycle metabolic process (GO:0071941) | 3.04719383 |
| 127 | positive regulation of cholesterol efflux (GO:0010875) | 3.04697975 |
| 128 | thioester metabolic process (GO:0035383) | 3.04498255 |
| 129 | acyl-CoA metabolic process (GO:0006637) | 3.04498255 |
| 130 | tricarboxylic acid metabolic process (GO:0072350) | 3.02999087 |
| 131 | leukocyte aggregation (GO:0070486) | 3.02847264 |
| 132 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.02375493 |
| 133 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.02375493 |
| 134 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.01311241 |
| 135 | diacylglycerol metabolic process (GO:0046339) | 3.01016882 |
| 136 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.99776052 |
| 137 | phospholipid efflux (GO:0033700) | 2.99597878 |
| 138 | plasma lipoprotein particle organization (GO:0071827) | 2.99079613 |
| 139 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.99028264 |
| 140 | glycerol metabolic process (GO:0006071) | 2.98478219 |
| 141 | lysine metabolic process (GO:0006553) | 2.95677321 |
| 142 | lysine catabolic process (GO:0006554) | 2.95677321 |
| 143 | positive regulation of lipid storage (GO:0010884) | 2.95530004 |
| 144 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.95314495 |
| 145 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.95042371 |
| 146 | regulation of protein activation cascade (GO:2000257) | 2.93711475 |
| 147 | cytidine deamination (GO:0009972) | 2.92857208 |
| 148 | cytidine metabolic process (GO:0046087) | 2.92857208 |
| 149 | cytidine catabolic process (GO:0006216) | 2.92857208 |
| 150 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.89661080 |
| 151 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.82762797 |
| 152 | Peyers patch development (GO:0048541) | 2.82522134 |
| 153 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.82522134 |
| 154 | positive regulation of granulocyte differentiation (GO:0030854) | 2.82362568 |
| 155 | cellular response to epinephrine stimulus (GO:0071872) | 2.81443709 |
| 156 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.78393958 |
| 157 | detection of calcium ion (GO:0005513) | 2.77808559 |
| 158 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.76261338 |
| 159 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.75011548 |
| 160 | negative regulation of adaptive immune response (GO:0002820) | 2.71863938 |
| 161 | neurotransmitter uptake (GO:0001504) | 2.68467996 |
| 162 | microglial cell activation (GO:0001774) | 2.68215138 |
| 163 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.67470900 |
| 164 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.66867755 |
| 165 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.66691018 |
| 166 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.66341176 |
| 167 | positive regulation of interleukin-4 production (GO:0032753) | 2.65826426 |
| 168 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.64573824 |
| 169 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.64062298 |
| 170 | negative regulation of neurotransmitter transport (GO:0051589) | 2.63170291 |
| 171 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.62846953 |
| 172 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.62134340 |
| 173 | regulation of protein kinase A signaling (GO:0010738) | 2.61912266 |
| 174 | T cell differentiation (GO:0030217) | 2.59658566 |
| 175 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.59058339 |
| 176 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.58649364 |
| 177 | regulation of cell killing (GO:0031341) | 2.58182571 |
| 178 | neuronal action potential propagation (GO:0019227) | 2.58161742 |
| 179 | negative regulation of B cell proliferation (GO:0030889) | 2.54893678 |
| 180 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.54351114 |
| 181 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.54130012 |
| 182 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.53992238 |
| 183 | positive regulation of interleukin-2 production (GO:0032743) | 2.53306165 |
| 184 | positive regulation of cell killing (GO:0031343) | 2.53097099 |
| 185 | lymphocyte migration (GO:0072676) | 2.52761276 |
| 186 | alpha-beta T cell differentiation (GO:0046632) | 2.49964294 |
| 187 | synaptic vesicle maturation (GO:0016188) | 2.48165981 |
| 188 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.47698746 |
| 189 | type I interferon signaling pathway (GO:0060337) | 2.46137437 |
| 190 | cellular response to type I interferon (GO:0071357) | 2.46137437 |
| 191 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.45719835 |
| 192 | regulation of synaptic vesicle transport (GO:1902803) | 2.44632758 |
| 193 | T cell mediated immunity (GO:0002456) | 2.43948041 |
| 194 | response to type I interferon (GO:0034340) | 2.43175816 |
| 195 | mast cell activation (GO:0045576) | 2.38360222 |
| 196 | T cell costimulation (GO:0031295) | 2.38068410 |
| 197 | regulation of platelet aggregation (GO:0090330) | 2.37561498 |
| 198 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.36508087 |
| 199 | L-amino acid import (GO:0043092) | 2.35149280 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.87823822 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.80444977 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.78713752 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.35197051 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.28877209 |
| 6 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.03571123 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.92908871 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.34723065 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.99203156 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.97345933 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.95485267 |
| 12 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.86223789 |
| 13 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.78503512 |
| 14 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.69807129 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.33640380 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.27423498 |
| 17 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.15768135 |
| 18 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.05009094 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 10.4303255 |
| 20 | * MYB_26560356_Chip-Seq_TH2_Human | 1.88988938 |
| 21 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.83530484 |
| 22 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.82201904 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.78731411 |
| 24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.73021827 |
| 25 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.72119762 |
| 26 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.72058793 |
| 27 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.71985148 |
| 28 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.67139842 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.60151258 |
| 30 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.59013463 |
| 31 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.53199775 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.52843866 |
| 33 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.45056158 |
| 34 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43595749 |
| 35 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.43352545 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.43309546 |
| 37 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.42840819 |
| 38 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.39862687 |
| 39 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.39419457 |
| 40 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.39187534 |
| 41 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.38425252 |
| 42 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.37304535 |
| 43 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.35254844 |
| 44 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.34506464 |
| 45 | MYB_26560356_Chip-Seq_TH1_Human | 1.34404052 |
| 46 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.32593065 |
| 47 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.31192597 |
| 48 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30959179 |
| 49 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.29829482 |
| 50 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.28416239 |
| 51 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.27177077 |
| 52 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.26610149 |
| 53 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.24463901 |
| 54 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.23966339 |
| 55 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23966339 |
| 56 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.23824248 |
| 57 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.23302788 |
| 58 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.22861785 |
| 59 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.22556039 |
| 60 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.22556039 |
| 61 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21496455 |
| 62 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.21296934 |
| 63 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.20822755 |
| 64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.20573455 |
| 65 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.20236549 |
| 66 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20201862 |
| 67 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.20007226 |
| 68 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.18612413 |
| 69 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17878069 |
| 70 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.16137352 |
| 71 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.16072881 |
| 72 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.13668569 |
| 73 | TCF4_23295773_ChIP-Seq_U87_Human | 1.13307827 |
| 74 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.13175396 |
| 75 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.12370882 |
| 76 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.11869578 |
| 77 | TP53_16413492_ChIP-PET_HCT116_Human | 1.10722175 |
| 78 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08997968 |
| 79 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.08925909 |
| 80 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.07261155 |
| 81 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.07094114 |
| 82 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.05924908 |
| 83 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05356258 |
| 84 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.04256970 |
| 85 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.04239579 |
| 86 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.03822087 |
| 87 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.03798942 |
| 88 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.03770376 |
| 89 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03714595 |
| 90 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03714595 |
| 91 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.02491260 |
| 92 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.01639033 |
| 93 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01095658 |
| 94 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.00757592 |
| 95 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.00526160 |
| 96 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.99724780 |
| 97 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.98657976 |
| 98 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.98553049 |
| 99 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.98284650 |
| 100 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.97841278 |
| 101 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.97358112 |
| 102 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97188795 |
| 103 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.96623782 |
| 104 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.96531695 |
| 105 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.96300658 |
| 106 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.95172095 |
| 107 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.93325384 |
| 108 | SPI1_23127762_ChIP-Seq_K562_Human | 0.92686200 |
| 109 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.92639274 |
| 110 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.92038435 |
| 111 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.91396676 |
| 112 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.90868038 |
| 113 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.90816348 |
| 114 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.89883871 |
| 115 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.89522715 |
| 116 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.89394409 |
| 117 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.89123696 |
| 118 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.88453203 |
| 119 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.88344040 |
| 120 | AR_25329375_ChIP-Seq_VCAP_Human | 0.87931745 |
| 121 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.87056671 |
| 122 | RXR_22108803_ChIP-Seq_LS180_Human | 0.86194391 |
| 123 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.85275610 |
| 124 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.84968110 |
| 125 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.83856403 |
| 126 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.83707986 |
| 127 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82891060 |
| 128 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.82200076 |
| 129 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.81576254 |
| 130 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.81378065 |
| 131 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.81267158 |
| 132 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.81200543 |
| 133 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81066062 |
| 134 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.80152152 |
| 135 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.78345830 |
| 136 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.76078543 |
| 137 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.75864009 |
| 138 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.74792634 |
| 139 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.73243392 |
| 140 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.73243392 |
| 141 | GATA1_19941826_ChIP-Seq_K562_Human | 0.73184442 |
| 142 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.72367275 |
| 143 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.71978146 |
| 144 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.71858123 |
| 145 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.71858123 |
| 146 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.71834849 |
| 147 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.71832242 |
| 148 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.71754316 |
| 149 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.71056950 |
| 150 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.70234684 |
| 151 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.68796488 |
| 152 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.67051255 |
| 153 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.66625407 |
| 154 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.66289004 |
| 155 | CJUN_26792858_Chip-Seq_BT549_Human | 0.65286975 |
| 156 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.65281820 |
| 157 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65207247 |
| 158 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.64659529 |
| 159 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.64000720 |
| 160 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.63816177 |
| 161 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.63647912 |
| 162 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.63042397 |
| 163 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.62874026 |
| 164 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.62743482 |
| 165 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.62638722 |
| 166 | P300_19829295_ChIP-Seq_ESCs_Human | 0.62294166 |
| 167 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.61905169 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 6.74272091 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.37262250 |
| 3 | MP0004130_abnormal_muscle_cell | 4.20985971 |
| 4 | MP0005666_abnormal_adipose_tissue | 4.14892782 |
| 5 | MP0005360_urolithiasis | 3.98998146 |
| 6 | MP0010329_abnormal_lipoprotein_level | 3.98497132 |
| 7 | MP0005365_abnormal_bile_salt | 3.93402120 |
| 8 | MP0003763_abnormal_thymus_physiology | 3.43282700 |
| 9 | MP0005671_abnormal_response_to | 3.40954934 |
| 10 | MP0004185_abnormal_adipocyte_glucose | 3.34632620 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 3.12719085 |
| 12 | MP0002876_abnormal_thyroid_physiology | 3.06741256 |
| 13 | MP0005375_adipose_tissue_phenotype | 3.03526296 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 2.88299334 |
| 15 | MP0002971_abnormal_brown_adipose | 2.78268104 |
| 16 | MP0003303_peritoneal_inflammation | 2.53170537 |
| 17 | MP0005085_abnormal_gallbladder_physiolo | 2.50887756 |
| 18 | MP0000013_abnormal_adipose_tissue | 2.49125618 |
| 19 | * MP0002118_abnormal_lipid_homeostasis | 2.44494153 |
| 20 | MP0003787_abnormal_imprinting | 2.43492137 |
| 21 | MP0001800_abnormal_humoral_immune | 2.41116525 |
| 22 | MP0008875_abnormal_xenobiotic_pharmacok | 2.39439210 |
| 23 | MP0009115_abnormal_fat_cell | 2.39361985 |
| 24 | MP0001835_abnormal_antigen_presentation | 2.37521011 |
| 25 | MP0001968_abnormal_touch/_nociception | 2.36085939 |
| 26 | MP0003880_abnormal_central_pattern | 2.33643463 |
| 27 | MP0005334_abnormal_fat_pad | 2.30872898 |
| 28 | MP0008438_abnormal_cutaneous_collagen | 2.27022329 |
| 29 | MP0003690_abnormal_glial_cell | 2.17978581 |
| 30 | MP0002736_abnormal_nociception_after | 2.16268179 |
| 31 | MP0000003_abnormal_adipose_tissue | 2.04541568 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.94612264 |
| 33 | MP0005535_abnormal_body_temperature | 1.94125915 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.89747805 |
| 35 | MP0009745_abnormal_behavioral_response | 1.87546424 |
| 36 | MP0003635_abnormal_synaptic_transmissio | 1.87058391 |
| 37 | MP0004859_abnormal_synaptic_plasticity | 1.85475575 |
| 38 | MP0001819_abnormal_immune_cell | 1.83664865 |
| 39 | MP0000609_abnormal_liver_physiology | 1.83151533 |
| 40 | MP0003868_abnormal_feces_composition | 1.83141657 |
| 41 | MP0002723_abnormal_immune_serum | 1.80509393 |
| 42 | MP0008569_lethality_at_weaning | 1.79664066 |
| 43 | MP0002970_abnormal_white_adipose | 1.72939337 |
| 44 | MP0001661_extended_life_span | 1.72671027 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.69578709 |
| 46 | MP0003045_fibrosis | 1.67926669 |
| 47 | MP0001790_abnormal_immune_system | 1.66412329 |
| 48 | MP0005387_immune_system_phenotype | 1.66412329 |
| 49 | MP0002064_seizures | 1.65280035 |
| 50 | MP0005332_abnormal_amino_acid | 1.64502090 |
| 51 | MP0009785_altered_susceptibility_to | 1.64275962 |
| 52 | MP0000703_abnormal_thymus_morphology | 1.63138597 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.61673407 |
| 54 | MP0005025_abnormal_response_to | 1.61616671 |
| 55 | MP0002452_abnormal_antigen_presenting | 1.60007231 |
| 56 | MP0003252_abnormal_bile_duct | 1.59317334 |
| 57 | MP0002063_abnormal_learning/memory/cond | 1.54982207 |
| 58 | MP0002398_abnormal_bone_marrow | 1.54432745 |
| 59 | MP0005448_abnormal_energy_balance | 1.51146223 |
| 60 | MP0000685_abnormal_immune_system | 1.50652046 |
| 61 | MP0001486_abnormal_startle_reflex | 1.48407264 |
| 62 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.47525113 |
| 63 | * MP0000716_abnormal_immune_system | 1.45995726 |
| 64 | MP0001764_abnormal_homeostasis | 1.43291742 |
| 65 | MP0009840_abnormal_foam_cell | 1.42236072 |
| 66 | MP0001501_abnormal_sleep_pattern | 1.41357455 |
| 67 | MP0003186_abnormal_redox_activity | 1.38535763 |
| 68 | MP0001986_abnormal_taste_sensitivity | 1.37810513 |
| 69 | MP0002254_reproductive_system_inflammat | 1.36376918 |
| 70 | MP0003866_abnormal_defecation | 1.35898222 |
| 71 | MP0003959_abnormal_lean_body | 1.35552389 |
| 72 | MP0002078_abnormal_glucose_homeostasis | 1.33892839 |
| 73 | MP0008877_abnormal_DNA_methylation | 1.32237815 |
| 74 | MP0004381_abnormal_hair_follicle | 1.31165967 |
| 75 | MP0005319_abnormal_enzyme/_coenzyme | 1.31062437 |
| 76 | MP0005423_abnormal_somatic_nervous | 1.30501023 |
| 77 | MP0002419_abnormal_innate_immunity | 1.30171944 |
| 78 | MP0003705_abnormal_hypodermis_morpholog | 1.29128011 |
| 79 | MP0005275_abnormal_skin_tensile | 1.26183856 |
| 80 | MP0002722_abnormal_immune_system | 1.24759340 |
| 81 | MP0000689_abnormal_spleen_morphology | 1.24109267 |
| 82 | * MP0002272_abnormal_nervous_system | 1.22098332 |
| 83 | MP0003436_decreased_susceptibility_to | 1.21676592 |
| 84 | MP0009046_muscle_twitch | 1.21302189 |
| 85 | MP0002067_abnormal_sensory_capabilities | 1.21153575 |
| 86 | MP0003724_increased_susceptibility_to | 1.16080734 |
| 87 | MP0009780_abnormal_chondrocyte_physiolo | 1.15948370 |
| 88 | MP0002405_respiratory_system_inflammati | 1.15502874 |
| 89 | MP0000604_amyloidosis | 1.14090795 |
| 90 | MP0005452_abnormal_adipose_tissue | 1.14029784 |
| 91 | MP0002909_abnormal_adrenal_gland | 1.11932264 |
| 92 | MP0002572_abnormal_emotion/affect_behav | 1.09546770 |
| 93 | MP0004924_abnormal_behavior | 1.08459170 |
| 94 | MP0005386_behavior/neurological_phenoty | 1.08459170 |
| 95 | MP0005310_abnormal_salivary_gland | 1.05869611 |
| 96 | MP0000920_abnormal_myelination | 1.02681581 |
| 97 | MP0003806_abnormal_nucleotide_metabolis | 1.01630327 |
| 98 | MP0004019_abnormal_vitamin_homeostasis | 0.98121449 |
| 99 | MP0005075_abnormal_melanosome_morpholog | 0.98076748 |
| 100 | MP0002090_abnormal_vision | 0.96929303 |
| 101 | MP0001666_abnormal_nutrient_absorption | 0.96762733 |
| 102 | MP0003011_delayed_dark_adaptation | 0.96076004 |
| 103 | MP0002733_abnormal_thermal_nociception | 0.95099684 |
| 104 | MP0003075_altered_response_to | 0.94578086 |
| 105 | MP0001970_abnormal_pain_threshold | 0.92853271 |
| 106 | MP0005174_abnormal_tail_pigmentation | 0.92582049 |
| 107 | * MP0002429_abnormal_blood_cell | 0.91354183 |
| 108 | MP0005058_abnormal_lysosome_morphology | 0.90527429 |
| 109 | MP0005645_abnormal_hypothalamus_physiol | 0.90352627 |
| 110 | MP0004134_abnormal_chest_morphology | 0.88997306 |
| 111 | MP0001881_abnormal_mammary_gland | 0.86959066 |
| 112 | MP0006036_abnormal_mitochondrial_physio | 0.86122236 |
| 113 | MP0002009_preneoplasia | 0.83583722 |
| 114 | MP0001845_abnormal_inflammatory_respons | 0.82319522 |
| 115 | MP0003329_amyloid_beta_deposits | 0.82019575 |
| 116 | MP0009763_increased_sensitivity_to | 0.81879545 |
| 117 | MP0000343_altered_response_to | 0.81312958 |
| 118 | MP0003953_abnormal_hormone_level | 0.80955220 |
| 119 | MP0002638_abnormal_pupillary_reflex | 0.80543349 |
| 120 | MP0000015_abnormal_ear_pigmentation | 0.80399009 |
| 121 | MP0002006_tumorigenesis | 0.79237832 |
| 122 | MP0001440_abnormal_grooming_behavior | 0.79120389 |
| 123 | MP0004484_altered_response_of | 0.78120992 |
| 124 | MP0001984_abnormal_olfaction | 0.77768644 |
| 125 | MP0005164_abnormal_response_to | 0.77345589 |
| 126 | MP0009643_abnormal_urine_homeostasis | 0.75625496 |
| 127 | MP0004043_abnormal_pH_regulation | 0.75066852 |
| 128 | * MP0003631_nervous_system_phenotype | 0.74182008 |
| 129 | MP0008961_abnormal_basal_metabolism | 0.73766595 |
| 130 | MP0004742_abnormal_vestibular_system | 0.73410309 |
| 131 | MP0004885_abnormal_endolymph | 0.73388089 |
| 132 | MP0005595_abnormal_vascular_smooth | 0.72395413 |
| 133 | MP0002133_abnormal_respiratory_system | 0.72359848 |
| 134 | MP0005388_respiratory_system_phenotype | 0.72359848 |
| 135 | MP0009764_decreased_sensitivity_to | 0.72130925 |
| 136 | MP0004147_increased_porphyrin_level | 0.71986200 |
| 137 | MP0005647_abnormal_sex_gland | 0.71970170 |
| 138 | MP0002277_abnormal_respiratory_mucosa | 0.70887706 |
| 139 | MP0002095_abnormal_skin_pigmentation | 0.70805103 |
| 140 | MP0004270_analgesia | 0.70737112 |
| 141 | MP0001851_eye_inflammation | 0.70576804 |
| 142 | MP0002332_abnormal_exercise_endurance | 0.68067143 |
| 143 | MP0005379_endocrine/exocrine_gland_phen | 0.67643025 |
| 144 | MP0005620_abnormal_muscle_contractility | 0.65605644 |
| 145 | MP0000598_abnormal_liver_morphology | 0.64927750 |
| 146 | MP0003195_calcinosis | 0.64266542 |
| 147 | MP0008872_abnormal_physiological_respon | 0.63165912 |
| 148 | MP0009697_abnormal_copulation | 0.63098372 |
| 149 | MP0001177_atelectasis | 0.62987347 |
| 150 | MP0009642_abnormal_blood_homeostasis | 0.61693595 |
| 151 | MP0001756_abnormal_urination | 0.60859098 |
| 152 | MP0008874_decreased_physiological_sensi | 0.60736817 |
| 153 | MP0002069_abnormal_eating/drinking_beha | 0.60525872 |
| 154 | MP0000230_abnormal_systemic_arterial | 0.60100710 |
| 155 | MP0005083_abnormal_biliary_tract | 0.59363801 |
| 156 | MP0004215_abnormal_myocardial_fiber | 0.59329786 |
| 157 | MP0003656_abnormal_erythrocyte_physiolo | 0.59149712 |
| 158 | MP0005167_abnormal_blood-brain_barrier | 0.58943169 |
| 159 | MP0008775_abnormal_heart_ventricle | 0.58260405 |
| 160 | MP0005376_homeostasis/metabolism_phenot | 0.57330163 |
| 161 | MP0003646_muscle_fatigue | 0.56376222 |
| 162 | MP0004883_abnormal_blood_vessel | 0.56286557 |
| 163 | MP0004782_abnormal_surfactant_physiolog | 0.54648834 |
| 164 | * MP0003633_abnormal_nervous_system | 0.54603054 |
| 165 | MP0002166_altered_tumor_susceptibility | 0.54212471 |
| 166 | MP0003172_abnormal_lysosome_physiology | 0.52225674 |
| 167 | MP0003948_abnormal_gas_homeostasis | 0.52206194 |
| 168 | MP0002168_other_aberrant_phenotype | 0.51729981 |
| 169 | MP0000249_abnormal_blood_vessel | 0.51525318 |
| 170 | MP0006276_abnormal_autonomic_nervous | 0.50891463 |
| 171 | MP0009672_abnormal_birth_weight | 0.50813924 |
| 172 | MP0006138_congestive_heart_failure | 0.50652033 |
| 173 | MP0000569_abnormal_digit_pigmentation | 0.50491619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oligomenorrhea (HP:0000876) | 6.04476007 |
| 2 | T lymphocytopenia (HP:0005403) | 5.83649403 |
| 3 | Hyperglycinuria (HP:0003108) | 5.43811781 |
| 4 | Abnormality of T cell number (HP:0011839) | 5.43103124 |
| 5 | Complement deficiency (HP:0004431) | 4.94658033 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 4.85721135 |
| 7 | Hemiplegia (HP:0002301) | 4.83552469 |
| 8 | Acanthosis nigricans (HP:0000956) | 4.82716061 |
| 9 | Abnormality of glycine metabolism (HP:0010895) | 4.80943709 |
| 10 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.80943709 |
| 11 | Hypertriglyceridemia (HP:0002155) | 4.80451101 |
| 12 | Hypoalphalipoproteinemia (HP:0003233) | 4.66633665 |
| 13 | Xanthomatosis (HP:0000991) | 4.58901849 |
| 14 | Autoimmune hemolytic anemia (HP:0001890) | 4.32501077 |
| 15 | Epidermoid cyst (HP:0200040) | 4.21959029 |
| 16 | Recurrent bronchitis (HP:0002837) | 4.18163427 |
| 17 | Deep venous thrombosis (HP:0002625) | 4.16671692 |
| 18 | Ketosis (HP:0001946) | 4.13960082 |
| 19 | Hyperammonemia (HP:0001987) | 4.02313752 |
| 20 | Hypoglycemic coma (HP:0001325) | 3.96420269 |
| 21 | Hyperglycinemia (HP:0002154) | 3.89542131 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.88190340 |
| 23 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.83230752 |
| 24 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.76086365 |
| 25 | Focal motor seizures (HP:0011153) | 3.69139816 |
| 26 | Hypolipoproteinemia (HP:0010981) | 3.67591321 |
| 27 | Ketoacidosis (HP:0001993) | 3.62156019 |
| 28 | Abnormality of complement system (HP:0005339) | 3.53603105 |
| 29 | IgG deficiency (HP:0004315) | 3.49986757 |
| 30 | Stomach cancer (HP:0012126) | 3.49250178 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.43902260 |
| 32 | Severe combined immunodeficiency (HP:0004430) | 3.43814322 |
| 33 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.40312544 |
| 34 | Myoglobinuria (HP:0002913) | 3.39570243 |
| 35 | Abnormality of T cells (HP:0002843) | 3.37827689 |
| 36 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.34908922 |
| 37 | Pigmentary retinal degeneration (HP:0001146) | 3.27001313 |
| 38 | Thyroiditis (HP:0100646) | 3.25352790 |
| 39 | Prolonged partial thromboplastin time (HP:0003645) | 3.24039729 |
| 40 | Eczematoid dermatitis (HP:0000976) | 3.21609300 |
| 41 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.14360506 |
| 42 | Myocardial infarction (HP:0001658) | 3.13421803 |
| 43 | Abnormality of proline metabolism (HP:0010907) | 3.12665592 |
| 44 | Hydroxyprolinuria (HP:0003080) | 3.12665592 |
| 45 | Systemic lupus erythematosus (HP:0002725) | 3.11177881 |
| 46 | Long foot (HP:0001833) | 3.09704710 |
| 47 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.07188250 |
| 48 | Recurrent fungal infections (HP:0002841) | 3.06560102 |
| 49 | Abnormality of eosinophils (HP:0001879) | 3.04387012 |
| 50 | Stomatitis (HP:0010280) | 2.99222940 |
| 51 | Hemorrhage of the eye (HP:0011885) | 2.96523384 |
| 52 | Joint hemorrhage (HP:0005261) | 2.96106477 |
| 53 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.95909763 |
| 54 | Recurrent bacterial skin infections (HP:0005406) | 2.89035847 |
| 55 | Progressive cerebellar ataxia (HP:0002073) | 2.88127643 |
| 56 | Skin nodule (HP:0200036) | 2.87611111 |
| 57 | Intrahepatic cholestasis (HP:0001406) | 2.87459611 |
| 58 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.86896145 |
| 59 | Dicarboxylic aciduria (HP:0003215) | 2.86896145 |
| 60 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.83486872 |
| 61 | Recurrent cutaneous fungal infections (HP:0011370) | 2.83486872 |
| 62 | Amyloidosis (HP:0011034) | 2.80516221 |
| 63 | Gastrointestinal infarctions (HP:0005244) | 2.79272237 |
| 64 | Abnormality of binocular vision (HP:0011514) | 2.78208348 |
| 65 | Diplopia (HP:0000651) | 2.78208348 |
| 66 | Truncal ataxia (HP:0002078) | 2.76915411 |
| 67 | Chest pain (HP:0100749) | 2.74803345 |
| 68 | Encephalitis (HP:0002383) | 2.74070620 |
| 69 | Hypobetalipoproteinemia (HP:0003563) | 2.73314479 |
| 70 | Eosinophilia (HP:0001880) | 2.73063785 |
| 71 | Meningitis (HP:0001287) | 2.70428316 |
| 72 | Increased IgM level (HP:0003496) | 2.68751746 |
| 73 | Recurrent abscess formation (HP:0002722) | 2.68218071 |
| 74 | Febrile seizures (HP:0002373) | 2.67884375 |
| 75 | Panhypogammaglobulinemia (HP:0003139) | 2.66935935 |
| 76 | Papilledema (HP:0001085) | 2.63846086 |
| 77 | IgM deficiency (HP:0002850) | 2.63022700 |
| 78 | Leukocytosis (HP:0001974) | 2.60340405 |
| 79 | Growth hormone excess (HP:0000845) | 2.59396155 |
| 80 | Abnormality of serum amino acid levels (HP:0003112) | 2.58733368 |
| 81 | Insulin resistance (HP:0000855) | 2.57252597 |
| 82 | Colitis (HP:0002583) | 2.56159105 |
| 83 | Retrobulbar optic neuritis (HP:0100654) | 2.51927561 |
| 84 | Optic neuritis (HP:0100653) | 2.51927561 |
| 85 | Agammaglobulinemia (HP:0004432) | 2.51497486 |
| 86 | Pancreatitis (HP:0001733) | 2.51058455 |
| 87 | Abnormality of B cell number (HP:0010975) | 2.50873648 |
| 88 | Hypoplasia of the thymus (HP:0000778) | 2.49165061 |
| 89 | Mediastinal lymphadenopathy (HP:0100721) | 2.47708096 |
| 90 | Subacute progressive viral hepatitis (HP:0006572) | 2.46986974 |
| 91 | Recurrent viral infections (HP:0004429) | 2.46606157 |
| 92 | Hepatoblastoma (HP:0002884) | 2.45510509 |
| 93 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.45152023 |
| 94 | Lymphopenia (HP:0001888) | 2.44520655 |
| 95 | Papillary thyroid carcinoma (HP:0002895) | 2.44222059 |
| 96 | Acute hepatic failure (HP:0006554) | 2.44194783 |
| 97 | Inflammation of the large intestine (HP:0002037) | 2.43527819 |
| 98 | Subcapsular cataract (HP:0000523) | 2.43140098 |
| 99 | Rhabdomyolysis (HP:0003201) | 2.42829404 |
| 100 | Action tremor (HP:0002345) | 2.41488679 |
| 101 | Focal seizures (HP:0007359) | 2.39814238 |
| 102 | Abnormality of the common coagulation pathway (HP:0010990) | 2.38272867 |
| 103 | Amyotrophic lateral sclerosis (HP:0007354) | 2.38173712 |
| 104 | Thyroid-stimulating hormone excess (HP:0002925) | 2.37489240 |
| 105 | B lymphocytopenia (HP:0010976) | 2.36511965 |
| 106 | Spontaneous hematomas (HP:0007420) | 2.35709734 |
| 107 | Myositis (HP:0100614) | 2.35673012 |
| 108 | Protruding tongue (HP:0010808) | 2.35202135 |
| 109 | Recurrent skin infections (HP:0001581) | 2.35148384 |
| 110 | Bone cyst (HP:0012062) | 2.29998618 |
| 111 | Combined immunodeficiency (HP:0005387) | 2.27975165 |
| 112 | Postural instability (HP:0002172) | 2.26745957 |
| 113 | Vasculitis (HP:0002633) | 2.26548424 |
| 114 | Bronchitis (HP:0012387) | 2.24150825 |
| 115 | Granulocytopenia (HP:0001913) | 2.24079241 |
| 116 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.23661453 |
| 117 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.23529382 |
| 118 | Epileptic encephalopathy (HP:0200134) | 2.22744771 |
| 119 | Hypoglycemic seizures (HP:0002173) | 2.20381171 |
| 120 | Abnormality of purine metabolism (HP:0004352) | 2.19460912 |
| 121 | Gastrointestinal inflammation (HP:0004386) | 2.19073695 |
| 122 | Metabolic acidosis (HP:0001942) | 2.18920324 |
| 123 | Myokymia (HP:0002411) | 2.18455986 |
| 124 | Abnormal eating behavior (HP:0100738) | 2.18027803 |
| 125 | Prenatal maternal abnormality (HP:0002686) | 2.14007018 |
| 126 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.12971941 |
| 127 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.12333046 |
| 128 | Viral hepatitis (HP:0006562) | 2.11921686 |
| 129 | Brushfield spots (HP:0001088) | 2.11768389 |
| 130 | Hypoproteinemia (HP:0003075) | 2.10673964 |
| 131 | Atonic seizures (HP:0010819) | 2.09265401 |
| 132 | Slow saccadic eye movements (HP:0000514) | 2.08988058 |
| 133 | Pulmonary infiltrates (HP:0002113) | 2.08796418 |
| 134 | Orchitis (HP:0100796) | 2.08181989 |
| 135 | Tetraparesis (HP:0002273) | 2.08077799 |
| 136 | Difficulty running (HP:0009046) | 2.07816233 |
| 137 | Nausea (HP:0002018) | 2.05989654 |
| 138 | Toxemia of pregnancy (HP:0100603) | 2.04863822 |
| 139 | Hyperpituitarism (HP:0010514) | 2.04782606 |
| 140 | Genetic anticipation (HP:0003743) | 2.03903280 |
| 141 | Increased muscle lipid content (HP:0009058) | 2.03235674 |
| 142 | Papilloma (HP:0012740) | 2.03122719 |
| 143 | Verrucae (HP:0200043) | 2.03122719 |
| 144 | Hypochromic microcytic anemia (HP:0004840) | 2.02388471 |
| 145 | Lethargy (HP:0001254) | 2.02368246 |
| 146 | Hyperthyroidism (HP:0000836) | 2.01959561 |
| 147 | Neonatal hypoglycemia (HP:0001998) | 2.00820843 |
| 148 | Keratoconjunctivitis sicca (HP:0001097) | 2.00182911 |
| 149 | Glomerulonephritis (HP:0000099) | 2.00016034 |
| 150 | IgA deficiency (HP:0002720) | 1.99378357 |
| 151 | Abnormality of methionine metabolism (HP:0010901) | 1.97994789 |
| 152 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.97144836 |
| 153 | Visual hallucinations (HP:0002367) | 1.96659630 |
| 154 | Chronic diarrhea (HP:0002028) | 1.96611512 |
| 155 | Hemiparesis (HP:0001269) | 1.94356613 |
| 156 | Neoplasm of the adrenal cortex (HP:0100641) | 1.94169615 |
| 157 | Excessive salivation (HP:0003781) | 1.93051562 |
| 158 | Gingival bleeding (HP:0000225) | 1.92708977 |
| 159 | Hyperglycemia (HP:0003074) | 1.92280242 |
| 160 | Hyperventilation (HP:0002883) | 1.90807736 |
| 161 | Vomiting (HP:0002013) | 1.88502572 |
| 162 | Long nose (HP:0003189) | 1.88365797 |
| 163 | Sensorimotor neuropathy (HP:0007141) | 1.88340624 |
| 164 | Large hands (HP:0001176) | 1.87312823 |
| 165 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.87227266 |
| 166 | Glucose intolerance (HP:0000833) | 1.87205474 |
| 167 | Hemoptysis (HP:0002105) | 1.86335421 |
| 168 | Chronic sinusitis (HP:0011109) | 1.84108583 |
| 169 | Generalized aminoaciduria (HP:0002909) | 1.84020109 |
| 170 | Delayed CNS myelination (HP:0002188) | 1.83294797 |
| 171 | Gaze-evoked nystagmus (HP:0000640) | 1.82849364 |
| 172 | Accelerated skeletal maturation (HP:0005616) | 1.82398001 |
| 173 | Polygenic inheritance (HP:0010982) | 1.82353032 |
| 174 | Cholelithiasis (HP:0001081) | 1.81982015 |
| 175 | Abnormal gallbladder morphology (HP:0012437) | 1.80734868 |
| 176 | Exercise-induced myalgia (HP:0003738) | 1.80506034 |
| 177 | Keratoconjunctivitis (HP:0001096) | 1.80232812 |
| 178 | Nephritis (HP:0000123) | 1.79521769 |
| 179 | Poor eye contact (HP:0000817) | 1.79257258 |
| 180 | Abnormality of nucleobase metabolism (HP:0010932) | 1.78984649 |
| 181 | Cerebral edema (HP:0002181) | 1.76303122 |
| 182 | Hyperbilirubinemia (HP:0002904) | 1.75746665 |
| 183 | Central scotoma (HP:0000603) | 1.75260439 |
| 184 | Abnormal gallbladder physiology (HP:0012438) | 1.74900314 |
| 185 | Cholecystitis (HP:0001082) | 1.74900314 |
| 186 | Polyphagia (HP:0002591) | 1.68468847 |
| 187 | Renal cortical cysts (HP:0000803) | 1.68043269 |
| 188 | Limb hypertonia (HP:0002509) | 1.66370218 |
| 189 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.66162763 |
| 190 | Abnormality of the intrinsic pathway (HP:0010989) | 1.65930674 |
| 191 | Abnormality of the lumbar spine (HP:0100712) | 1.65897469 |
| 192 | Methylmalonic aciduria (HP:0012120) | 1.64411942 |
| 193 | Upper motor neuron abnormality (HP:0002127) | 1.64364578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMK1D | 5.78432917 |
| 2 | SIK1 | 4.45185968 |
| 3 | BCKDK | 4.39529695 |
| 4 | TRIB3 | 4.29002186 |
| 5 | CAMK1G | 4.27218048 |
| 6 | TXK | 4.17815921 |
| 7 | MAP4K1 | 3.20030907 |
| 8 | INSRR | 3.18296769 |
| 9 | RIPK1 | 2.69971597 |
| 10 | MARK1 | 2.41965877 |
| 11 | LMTK2 | 1.97217149 |
| 12 | DAPK2 | 1.89924756 |
| 13 | MAP4K2 | 1.88024588 |
| 14 | PRKAA2 | 1.86159800 |
| 15 | IKBKE | 1.82517649 |
| 16 | MAPK13 | 1.82446446 |
| 17 | ITK | 1.79829492 |
| 18 | GRK6 | 1.75125817 |
| 19 | ERN1 | 1.73418479 |
| 20 | PHKG2 | 1.73173052 |
| 21 | PHKG1 | 1.73173052 |
| 22 | MAP2K4 | 1.71236854 |
| 23 | BLK | 1.70247705 |
| 24 | MST1R | 1.69950893 |
| 25 | PDK4 | 1.68120685 |
| 26 | PDK3 | 1.68120685 |
| 27 | SYK | 1.66421946 |
| 28 | MAP3K10 | 1.56046175 |
| 29 | EPHA3 | 1.55638641 |
| 30 | WNK3 | 1.54598307 |
| 31 | FGFR2 | 1.53948269 |
| 32 | TAOK3 | 1.52072237 |
| 33 | FGFR3 | 1.49969926 |
| 34 | MAP3K6 | 1.44129304 |
| 35 | CCNB1 | 1.40091201 |
| 36 | JAK3 | 1.38221145 |
| 37 | TEC | 1.32381586 |
| 38 | NLK | 1.31004289 |
| 39 | TGFBR2 | 1.25188619 |
| 40 | BTK | 1.24566948 |
| 41 | PINK1 | 1.22964565 |
| 42 | FGFR4 | 1.13114205 |
| 43 | FRK | 1.12706724 |
| 44 | LCK | 1.11532367 |
| 45 | CDK9 | 1.11373872 |
| 46 | MAP3K4 | 1.11335939 |
| 47 | YES1 | 1.09946814 |
| 48 | TNK2 | 1.07989753 |
| 49 | PRKAA1 | 1.04271655 |
| 50 | LYN | 1.04020044 |
| 51 | BCR | 1.03563138 |
| 52 | MAPK11 | 1.02992470 |
| 53 | JAK1 | 1.02841063 |
| 54 | HCK | 1.01196420 |
| 55 | CAMKK2 | 1.00995536 |
| 56 | PRKCQ | 0.99633558 |
| 57 | PKN2 | 0.97968988 |
| 58 | PDPK1 | 0.95652143 |
| 59 | EPHA4 | 0.95530975 |
| 60 | MAP3K14 | 0.94316275 |
| 61 | PDK2 | 0.94164083 |
| 62 | SGK3 | 0.90360894 |
| 63 | IRAK4 | 0.85936913 |
| 64 | NEK9 | 0.85551698 |
| 65 | SGK2 | 0.85357114 |
| 66 | UHMK1 | 0.85344800 |
| 67 | SGK494 | 0.83891595 |
| 68 | SGK223 | 0.83891595 |
| 69 | PIM1 | 0.83734547 |
| 70 | CDK6 | 0.83720282 |
| 71 | JAK2 | 0.83204028 |
| 72 | FGR | 0.82812133 |
| 73 | KDR | 0.82389217 |
| 74 | PRKACG | 0.81986743 |
| 75 | PRPF4B | 0.81294911 |
| 76 | MAP2K1 | 0.79050482 |
| 77 | PDK1 | 0.77891603 |
| 78 | MAP2K7 | 0.75161348 |
| 79 | ZAP70 | 0.74931618 |
| 80 | PAK6 | 0.74515426 |
| 81 | FYN | 0.74208616 |
| 82 | TYRO3 | 0.73326943 |
| 83 | CSF1R | 0.73189808 |
| 84 | MAPK7 | 0.71722344 |
| 85 | TAOK1 | 0.70477236 |
| 86 | CAMKK1 | 0.70449208 |
| 87 | PIK3CA | 0.69820230 |
| 88 | PRKCH | 0.69741154 |
| 89 | RET | 0.69631905 |
| 90 | CAMK1 | 0.69450045 |
| 91 | ERBB3 | 0.68907577 |
| 92 | MAPK12 | 0.68901854 |
| 93 | NTRK2 | 0.67987698 |
| 94 | RAF1 | 0.67898541 |
| 95 | IRAK1 | 0.65861561 |
| 96 | CSNK1A1L | 0.65643514 |
| 97 | CDK19 | 0.64621099 |
| 98 | MINK1 | 0.62956714 |
| 99 | IGF1R | 0.61323253 |
| 100 | PRKD3 | 0.61314566 |
| 101 | TIE1 | 0.60375948 |
| 102 | MAP3K13 | 0.60330442 |
| 103 | IKBKB | 0.58552011 |
| 104 | BMPR2 | 0.57363636 |
| 105 | PTK2B | 0.56725541 |
| 106 | TNIK | 0.55202932 |
| 107 | CASK | 0.54894915 |
| 108 | KIT | 0.54665278 |
| 109 | CSNK1G2 | 0.54219783 |
| 110 | PLK2 | 0.54165987 |
| 111 | MARK3 | 0.52468483 |
| 112 | DYRK1A | 0.52244978 |
| 113 | MAP3K7 | 0.51465259 |
| 114 | PKN1 | 0.50493815 |
| 115 | PDGFRA | 0.50308946 |
| 116 | RPS6KB1 | 0.49302796 |
| 117 | DAPK1 | 0.49064186 |
| 118 | PRKCZ | 0.48465910 |
| 119 | IRAK3 | 0.48379803 |
| 120 | HIPK2 | 0.47572258 |
| 121 | PAK3 | 0.47219751 |
| 122 | KSR1 | 0.47092573 |
| 123 | STK38 | 0.46411445 |
| 124 | CSNK1G3 | 0.44847098 |
| 125 | NTRK3 | 0.43779029 |
| 126 | MAPK4 | 0.42714920 |
| 127 | FER | 0.42659818 |
| 128 | FES | 0.41637935 |
| 129 | CAMK2A | 0.41620160 |
| 130 | ERBB2 | 0.41531725 |
| 131 | CLK1 | 0.41335743 |
| 132 | FGFR1 | 0.40893812 |
| 133 | CDK5 | 0.40274956 |
| 134 | TYK2 | 0.40051735 |
| 135 | MAP2K3 | 0.40026473 |
| 136 | STK11 | 0.39167179 |
| 137 | CAMK4 | 0.37227487 |
| 138 | PIK3CG | 0.36164790 |
| 139 | FLT3 | 0.34376688 |
| 140 | SIK2 | 0.34047232 |
| 141 | IRAK2 | 0.33989182 |
| 142 | KSR2 | 0.33052308 |
| 143 | RPS6KA3 | 0.32639392 |
| 144 | CSK | 0.30703176 |
| 145 | PRKG1 | 0.29819878 |
| 146 | SRC | 0.29439618 |
| 147 | PRKACA | 0.29255339 |
| 148 | PRKD1 | 0.29107671 |
| 149 | GSK3A | 0.29017100 |
| 150 | SGK1 | 0.28825802 |
| 151 | TAOK2 | 0.28153298 |
| 152 | ABL2 | 0.26253631 |
| 153 | INSR | 0.25488904 |
| 154 | PRKG2 | 0.25419655 |
| 155 | GRK5 | 0.25363804 |
| 156 | RIPK4 | 0.24742933 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.65929798 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.56082549 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.53223845 |
| 4 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.48855653 |
| 5 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.34402575 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.07755220 |
| 7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.99699034 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.92568117 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.71459320 |
| 10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.57419628 |
| 11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.47838086 |
| 12 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.44227897 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.26865831 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.18416715 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.16664260 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.10000166 |
| 17 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.09152065 |
| 18 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.09101525 |
| 19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.06216232 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.02106417 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.96066002 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.92076181 |
| 23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.90218262 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.85329014 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.83134966 |
| 26 | * Peroxisome_Homo sapiens_hsa04146 | 1.82211650 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.82028009 |
| 28 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.81766953 |
| 29 | Allograft rejection_Homo sapiens_hsa05330 | 1.80867330 |
| 30 | Long-term potentiation_Homo sapiens_hsa04720 | 1.79434115 |
| 31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.74524872 |
| 32 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.73302107 |
| 33 | Measles_Homo sapiens_hsa05162 | 1.70746040 |
| 34 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.67857723 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.55776910 |
| 36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.55189507 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.53364025 |
| 38 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.52652363 |
| 39 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.46152915 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44513029 |
| 41 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.42753213 |
| 42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.41412739 |
| 43 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.35924393 |
| 44 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.34914441 |
| 45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.34837218 |
| 46 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.33184244 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.31111541 |
| 48 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.24207879 |
| 49 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.23663875 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.21795511 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.21715455 |
| 52 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21707115 |
| 53 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.19789265 |
| 54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.18715270 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.15782444 |
| 56 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.15270880 |
| 57 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.14173801 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.14071210 |
| 59 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.11936683 |
| 60 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.11573697 |
| 61 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.11046865 |
| 62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.10238792 |
| 63 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.10079685 |
| 64 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.09111027 |
| 65 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.07262899 |
| 66 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.05711033 |
| 67 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.04925737 |
| 68 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.04384039 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.03815631 |
| 70 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.03627917 |
| 71 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.03568420 |
| 72 | Malaria_Homo sapiens_hsa05144 | 1.01305631 |
| 73 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.00575669 |
| 74 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.99841620 |
| 75 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.97769106 |
| 76 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.97446173 |
| 77 | Histidine metabolism_Homo sapiens_hsa00340 | 0.97396914 |
| 78 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.97229390 |
| 79 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.96463396 |
| 80 | Bile secretion_Homo sapiens_hsa04976 | 0.96058427 |
| 81 | Leishmaniasis_Homo sapiens_hsa05140 | 0.94690176 |
| 82 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.93562669 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.92884224 |
| 84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.91851250 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.89813788 |
| 86 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89748605 |
| 87 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.89631252 |
| 88 | Glioma_Homo sapiens_hsa05214 | 0.88981363 |
| 89 | Viral myocarditis_Homo sapiens_hsa05416 | 0.88376672 |
| 90 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87837712 |
| 91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.87722897 |
| 92 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.87526639 |
| 93 | Tuberculosis_Homo sapiens_hsa05152 | 0.86941332 |
| 94 | Retinol metabolism_Homo sapiens_hsa00830 | 0.86770888 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.85051303 |
| 96 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.82540463 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82093173 |
| 98 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.81815900 |
| 99 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.80529117 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80400674 |
| 101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.78629923 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.76869390 |
| 103 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.75943491 |
| 104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.75726898 |
| 105 | * ABC transporters_Homo sapiens_hsa02010 | 0.75661027 |
| 106 | Long-term depression_Homo sapiens_hsa04730 | 0.75519510 |
| 107 | Taste transduction_Homo sapiens_hsa04742 | 0.73554474 |
| 108 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.70128047 |
| 109 | Renin secretion_Homo sapiens_hsa04924 | 0.67201638 |
| 110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66398725 |
| 111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.64066468 |
| 112 | Cocaine addiction_Homo sapiens_hsa05030 | 0.63877645 |
| 113 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63854571 |
| 114 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60595121 |
| 115 | Lysine degradation_Homo sapiens_hsa00310 | 0.60432987 |
| 116 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.60298974 |
| 117 | Hepatitis B_Homo sapiens_hsa05161 | 0.60029176 |
| 118 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.59546428 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59180906 |
| 120 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58417392 |
| 121 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58050419 |
| 122 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57694809 |
| 123 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57258915 |
| 124 | Insulin secretion_Homo sapiens_hsa04911 | 0.57059548 |
| 125 | Colorectal cancer_Homo sapiens_hsa05210 | 0.56375087 |
| 126 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56258882 |
| 127 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56163154 |
| 128 | Influenza A_Homo sapiens_hsa05164 | 0.54390476 |
| 129 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53989256 |
| 130 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53233294 |
| 131 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.52904682 |
| 132 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.52362251 |
| 133 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52147499 |
| 134 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.50675124 |
| 135 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49518407 |
| 136 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47044673 |
| 137 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43476194 |
| 138 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.39003826 |
| 139 | GABAergic synapse_Homo sapiens_hsa04727 | 0.35577038 |
| 140 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.35510604 |
| 141 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.34689076 |
| 142 | Olfactory transduction_Homo sapiens_hsa04740 | 0.31772397 |
| 143 | Salivary secretion_Homo sapiens_hsa04970 | 0.30663808 |
| 144 | Morphine addiction_Homo sapiens_hsa05032 | 0.30040399 |
| 145 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.27107795 |
| 146 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25756124 |
| 147 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.22799823 |
| 148 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.22782212 |
| 149 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.21682622 |
| 150 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.21314468 |
| 151 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.21140917 |
| 152 | Sulfur relay system_Homo sapiens_hsa04122 | 0.20956794 |
| 153 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.20656598 |
| 154 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19948664 |
| 155 | Galactose metabolism_Homo sapiens_hsa00052 | 0.17998880 |
| 156 | Lysosome_Homo sapiens_hsa04142 | 0.17992822 |
| 157 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.16639709 |
| 158 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.15832162 |
| 159 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.13094405 |
| 160 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.13025668 |
| 161 | Circadian entrainment_Homo sapiens_hsa04713 | 0.12880060 |
| 162 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.11976440 |
| 163 | Circadian rhythm_Homo sapiens_hsa04710 | 0.10481082 |
| 164 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.08720656 |
| 165 | Nicotine addiction_Homo sapiens_hsa05033 | 0.08151159 |
| 166 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.08091910 |
| 167 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.06107629 |
| 168 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.03310040 |
| 169 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.02236538 |
| 170 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.01438005 |
| 171 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.01215653 |
| 172 | Prion diseases_Homo sapiens_hsa05020 | 0.00925615 |

